Indian Journal of Urology Users online:861  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
SYMPOSIUM
Year : 2010  |  Volume : 26  |  Issue : 1  |  Page : 98-101

Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis


Department of Urology, University of Texas Health Science Center at San Antonio, Texas, USA

Correspondence Address:
Dipen J Parekh
Doctors Hospital at Renaissance Distinguished University Chair in Urology, Director of Robotic Surgery, Fellowship Director, Urologic Oncology, Associate Professor, Department of Urology, University of Texas Health Sciences Center at San Antonio, Texas
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0970-1591.60448

Rights and Permissions

The basis of treatment for advanced germ cell tumors is chemotherapy and surgical resection of residual disease. Surgery has maintained its role in staging and therapeutic management. Despite these advances, much of the outcomes depend on proper patient selection. Complete removal of all post-chemotherapy residual masses remains the standard of care in the treatment of advanced nonseminomatous germ cell tumors both within and outside of the retroperitoneum.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4233    
    Printed109    
    Emailed1    
    PDF Downloaded271    
    Comments [Add]    

Recommend this journal

 

HEALTHWARE INDIA